A citation-based method for searching scientific literature

Rajaa Nahra, Tao Wang, Kishore M Gadde, Jan Oscarsson, Michael Stumvoll, Lutz Jermutus, Boaz Hirshberg, Philip Ambery. Diabetes Care 2021
Times Cited: 42



Stephen A Harrison, Guy Neff, Cynthia D Guy, Mustafa R Bashir, Angelo H Paredes, Juan P Frias, Ziad Younes, James F Trotter, Nadege T Gunn, Sam E Moussa, Anita Kohli, Kristin Nelson, Mildred Gottwald, William C G Chang, Andrew Z Yan, Alex M DePaoli, Lei Ling, Hsiao D Lieu. Gastroenterology 2021
Times Cited: 93




List of shared articles



Times cited

Novel therapeutic targets for cholestatic and fatty liver disease.
Michael Trauner, Claudia Daniela Fuchs. Gut 2022
20

Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease.
Emily Brown, T Hydes, A Hamid, D J Cuthbertson. Clin Ther 2021
6

Current treatment of non-alcoholic fatty liver disease.
Rafael Paternostro, Michael Trauner. J Intern Med 2022
3

Impact of NAFLD and its pharmacotherapy on lipid profile and CVD.
Zhenya Wang, Mao Ye, Xiao-Jing Zhang, Peng Zhang, Jingjing Cai, Hongliang Li, Zhi-Gang She. Atherosclerosis 2022
0

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).
Xiaohan Xu, Kyle L Poulsen, Lijuan Wu, Shan Liu, Tatsunori Miyata, Qiaoling Song, Qingda Wei, Chenyang Zhao, Chunhua Lin, Jinbo Yang. Signal Transduct Target Ther 2022
0